Ristan Greer

May 1, 2024

Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer—a study protocol for a randomised controlled trial

Abstract Background: Distressing symptoms are common in advanced cancer. Medicinal cannabinoids are commonly prescribed for a variety of symptoms. There…

October 14, 2023

Exploring potential anti-inflammatory effects of medicinal cannabis

Abstract Purpose: Inflammation is thought to play a key role in malignant disease and may play a significant part in…

July 6, 2020

Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)

Abstract Background: Despite improvements in medical care, patients with advanced cancer still experience substantial symptom distress. There is increasing interest…

December 6, 2019

Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)

Abstract Background: Despite improvements in medical care, patients with advanced cancer still experience substantial symptom distress. There is increasing interest…